Evgen Pharma plc (EVG.L) – BUY*: US patent grant
15 Feb 2017
Northland Capital Partners Morning Report
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Northland Capital Partners Morning Report
Evgen Pharma Plc (EVG:LON) | 0.8 0 0.0% | Mkt Cap: 3.31m
- Published:
15 Feb 2017 -
Author:
Vadim Alexandre -
Pages:
4
Evgen Pharma plc (EVG.L) – BUY*: US patent grant